SCHEDULE: Vanguard Reports 5.3% Stake in HealthEquity

Vanguard Capital Management has disclosed beneficial ownership of 5.3% of HealthEquity Inc.'s common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, has reported beneficial ownership of 4,479,170 shares of HealthEquity Inc. common stock.
• This holding represents 5.3% of the total class of securities.
• Vanguard possesses sole voting power over 655,366 shares and sole dispositive power over 4,479,170 shares.
• The filing indicates that Vanguard funds and managed accounts have the right to receive dividends or direct the sale of these securities, but no single other person holds more than a 5% interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by a major investment firm and does not inherently signal positive or negative performance for HealthEquity.

Positives

• Vanguard's significant stake suggests confidence in HealthEquity's long-term prospects.
• The filing confirms Vanguard's role as a substantial institutional investor, which can provide stability and credibility.

Negatives

• The filing does not contain any negative financial or operational information about HealthEquity itself, as it is a disclosure of ownership by Vanguard.

Risks

• Potential for Vanguard to alter its holdings, which could impact HealthEquity's stock price.
• Changes in investment strategy by Vanguard could lead to a sale of shares, creating downward pressure on the stock.

Future Outlook

The filing itself is a snapshot of ownership and does not contain forward-looking statements or guidance from HealthEquity.

Industry Context

StockSavvy.ai notes that significant holdings by large asset managers like Vanguard often reflect a belief in the stability and growth potential of companies within the health savings and benefits administration sector.

Comparison to Industry Standards

• Vanguard's 5.3% stake in HealthEquity is a substantial position for an institutional investor, indicating a significant allocation of capital.
• For comparison, typical institutional ownership in publicly traded companies can range from single digits to over 80%, with large index fund managers like Vanguard often holding positions in the 3-10% range for companies within their benchmark indices.

Stakeholder Impact

• Shareholders: The presence of a large, stable institutional investor like Vanguard can be viewed positively, potentially increasing investor confidence.
• Management: May face increased scrutiny or engagement from Vanguard regarding corporate strategy and governance.
• Creditors: No direct impact indicated by this filing.

Next Steps

• Vanguard will continue to monitor its investment in HealthEquity.
• HealthEquity will continue its operations, subject to market conditions and its own strategic initiatives.

Key Dates

Keywords

HealthEquity, Vanguard, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management